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1. Introduction 
Preliminary examination of rat calcitonin (RCT) 
isolated as described in the preceding paper indicated 
a great similarity with human calcitonin (HCT). 
Immunochemical studies by ourselves [l] and other 
workers [2-41 lead also to this conclusion, and 
moreover sequence dissimilarity with further species 
of calcitonin may be inferred. The amino acid compo- 
sition of RCT [l] is Lysr , His,, Asxa, Thr4, Ser,, 
Glxz , Pro2 , Gly, , Alaa, Cys? , Valr , Met 1 , Iler , Lab, 
Tyrr , Phea . This differs from the composition of 
HCT at four points only, where the human hormone 
has Thrs , Serr , L.eu2 and Phe, . Thus, since only 
approx. 100 c(g of hormone was available for sequence 
studies, we elected to use a comparative approach 
using HCT as the model. 
2. Materials and methods 
2.1. Hormones 
Rat calcitonin was purified by gel filtration and 
column partition chromatography as described in the 
preceding paper. An estimated 100 pg was obtained 
by pooling the material remaining in both calcitonin 
immunoreactive peaks after preliminary characterisa- 
tion. Synthetic human calcitonin CIBA-47 175Ba 
was a generous gift from Dr W. Rittel, Ciba-Geigy 
Ltd., Basel, Switzerland. 
2.2. Peptide maps 
Short peptide fragments of RCT and HCT were 
generated by digestion with thermolysin for 16 h at 
37’C in 0.2 M pyridine acetate, pH 7.1; 200 ~1 for the 
RCT sample and 1 ml per mg for HCT. Enzyme:sub- 
strate ratios of 1: 20 for RCT and 1: 50 for HCT were 
used. The peptide fragments from each hormone were 
then separated on thin layers of cellulose (Merck, 
Darmstadt, Germany) by two-dimensional high 
voltage electrophoresis (pyridine-acetic acid-water, 
25: I:225 by vol., pH 6.5, 50 V/cm, 30 min) and 
chromatography (two runs in butanol-pyridine- 
acetic acid-water, 42:24:4:30 by vol). 
Peptide spots were located by their U.V. fluorescence 
after spraying with 0.05% w/v fluorescamine in 0.2% 
v/v pyridine in acetone [5]. Appropriate areas of the 
cellulose layer were then scraped off and eluted twice 
with 0.5 ml of the t.1.c. solvent and twice with 0.5 ml 
of 50%, v/v, acetic acid. The combined extracts were 
dried in vacua over NaOH and PaOe and then hydro- 
lysed in 6 M HCl in the presence of 10 pg phenol at 
110°C for 20 h under nitrogen in sealed tubes. 
Hydrolysates were analysed on a JEOL 6AH ammo 
acid analyser (JEOL Ltd., Tokyo, Japan), equipped 
with a 10 mm pathlength flowcell to increase 
sensitivity. 
2.3. End-group and sequence determinations 
Amino terminal residue determination by dansyla- 
tion and dansyl-Edman degradation were carried out 
as described by Hartley [6] . 
3. Results and discussion 
Thermolytic peptide maps (fig.1) of HCT contained 
eleven spots. The identity of the human peptide 
fragments was established after elution from the plate, 
by inspection of their amino acid compositions and 
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Fig.1. Peptide maps of the fragments obtained by thermo- 
lysin digestion of rat and human calcitonins. In the electro- 
phoretic run the cathode was to the left. Peptides in the 
HCT digest map are labelled with the residue numbers 
relevant o their position in the sequence; l-8 = 0 is the 
Mets sulphoxide derivative of the fragment sequence r sidues 
1-8. Peptides in the rat calcitonin digest are numbered 
lR-11R and their analytical data are presented in table 1. 
comparison with the known sequence of human 
calcitonin [7]. Two of these fragments represented 
the same sequence, residues l-8 of HCT, with one 
being the Met’ sulphoxide (1-8 = 0) derivative and 
the other being the native state; one spot was a 
mixture of two or more unidentified fragments. All 
residues of HCT except Alaz6 were accounted for in 
these fragments, some of them more than once. 
The pattern of the thermolytic fragments of RCT 
(fig. 1) contains eleven spots, 1 R- 11 R, which are 
very similar in their distribution to those obtained 
from HCT. 
The amino acid compositions and amino terminal 
residue of the pure RCT fragments are listed in table 
along with their proposed structures and position in 
the sequence. 
These sequences were derived from the position of 
a rat peptide in the peptide map, its amino acid 
composition and its end-group and by comparison 
Table 1 
Thermolytic fragments of rat calcitonin 
Peptide 
Amino 
terminus 
Amino acid 
composition Proposed structure 
(Residue 
numbers) 
1R 
2R :: 
3R 0 
4R LAXI 
5R Leu 
6R - 
7R - 
8R - 
9R Tyr 
10R - 
11R LJXI 
Pro Gly, Ala Val Ile 
Pro Gly Ala Val 
His Thr Glx Pro Ala Phe, 
Tlu Gly Leu 
Mixture 
Mixture 
Mixture 
Mixture 
Asx Tbr Glx Tyr 
Mixture 
Lys Asx Leu 
Ile-Gly-Val-Gly-Ala-Pro 
Val-Gly-Ala-Pro 
Phe-His-Ala/Tbr-Phe-Pro-Gln-Thr/Ala 
Leu-Gly-Thr 
- 
- 
_ 
- 
Tyr-Tbr-Gin-Asp 
_ 
Leu-Asn-Lys 
(27-32) 
(29-32) 
(19-25) 
( 9-11) 
(12-15) 
(16-18) 
a 0 = no end group detected. 
b - = dansylation not done.. 
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with data for the corresponding human peptide. 
Amide assignments were made by analogy with 
residues in HCT since in each case fragments from 
RCT containing Asx and Glx had the same electro- 
phoretic mobility as the corresponding peptide from 
HCT. The C-terminal fragments of RCT also had 
mobilities consistent with C-terminal proline being 
amidated. 
Low yields were obtained for amino terminal 
residues on amino acid analysis (except tyrosine in 
peptide 9R) no doubt due to blocking by fluores- 
camine. This confirmed results of dansylation, where 
obtained, and suggested Ile and Val as N-termini for 
sequences 27-32 and 29-32 respectively where no 
dansyl end group could be obtained. 
On this basis the rat calcitonin peptides lR, 2R, 
4R and 9R are identical to the peptides of sequence 
residues 27-32, 29-32,9- 11 and 12- 15 respectively 
in human calcitonin. 
Rat peptide 11 R corresponds in the peptide map 
with the human peptide sequence residues 16- 18 but 
the amino acid composition indicates the presence of 
leucine in place of the phenylalanine found in HCT. 
Dansylation shows this to be amino terminal and so 
the sequence is most probably Leu-Asn-Lys. 
The information available does not allow a definite 
assignment of the exchange seen in peptide 3R which 
has an overall resemblance to the sequence residues 
19-25 in human calcitonin. Here one of the two 
threonines (21 and 25) in HCT appears to have been 
replaced by alanine in RCT but there is no additional 
evidence to decide which. 
The peptides isolated in pure form account for 
residues 9-25 and 27-32 of rat calcitonin and leave, 
by subtraction from the total amino acid composition, 
Cys, , Gly, Asx, Leu, Thr, Serz , Met to fill sequence 
positions 1-8 and 26. 
Dansylation of the performic acid oxidised native 
RCT gave cysteic acid at sequence position one [I] . 
Dansyl-Edman degradation gave glycine for residue 
two. 
Mild oxidation with hydrogen peroxide to convert 
methionine to its sulphoxide destroyed the biological 
activity of RCT. This is characteristic of the two 
calcitonins (human and salmon III) which have 
methionine at position 8 [8,9] . Other species (porcine, 
ovine and bovine) with methionine at position 25 
retain biological activity after mild oxidation [lo] . It 
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H-Cys-Gly-Aon-Leu-Ser-Thr-Cys-Met- 
-v 
9 16 
Leu-Gly-Thr-Sr-Thr-Gln_Asp_Leu_ 
- -T - 
I 
4R 
* 
YR - 
17 
Asn-Lys-Phe-His- Thr/Ala-Phe-Pro-Zn- 
11R 4 3R 
25 
A1a/Thr-Ser-Ile-Gl_y-Val-Gly-Ala-~~o-MH2 
- 
1R * 
Fig.2. Proposed sequence for rat calcitonin. Numbered double- 
headed arrows indicate the peptides isolated by t.1.c. and 
listed in table 1. (-) Residues determined by dansylation. 
Positions 21 and 25 are occupied by alanine and threonine 
but the correct assignment could not be made. Residues 
numbers 1, 3, 4, 5, 6, 7, 9, 28 and 32 are those normally 
conserved in calcitonins. 
is likely, therefore, that RCT has methionine at 
position 8. 
If serine is then placed at position 26 the remaining 
amino acids may be placed in positions 3-7 in agree- 
ment with those normally found in this conserved 
region within calcitonins. ’ 
We therefore propose the sequence shown in fig.2 
for rat calcitonin. This sequence shows extensive 
homology with HCT which has Phe-16, Thr-21, Thr-25 
and Ala-26 in place of those shown. 
RCT is the first calcitonin to show such a large 
degree of homology with HCT. The amino acid 
exchanges found are in the C-terminal half of the 
molecule where antigenicity resides [ 11 ,I 21. They 
are too few to destroy binding to antibodies but 
clearly explain the reduced binding energy observed 
in the radioimmunoassay based on HCT [I] . 
It is interesting to note that RCT and HCT have 
closely similar structures and were both isolated from 
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thyroid medullary carcinoma. Both species differ 
markedly from all other known sequences which 
themselves fall into two distinct groups, typified by 
salmon and porcine calcitonins, and were isolated 
from normal tissue. 
However other work on rat calcitonin has employed 
material from normal thyroid tissue and indicates 
probable identity between ‘normal’ and ‘tumour’ rat 
calcitonins. In particular the provisional amino acid 
composition for ‘normal’ RCT published by Burford 
et al. [2] is essentially the same as that of our 
‘tumour’ RCT. And, in addition, extracts of normal 
rat thyroid and extracts of thyroid medullary 
carcinoma both cross-react in radioimmunoassays 
for human calcitonin (l-41 . 
We therefore feel that the structure in fig.2 
represents normal rat calcitonin. 
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